Welcome to our dedicated page for Confluent SEC filings (Ticker: CFLT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Confluent, Inc. (NASDAQ: CFLT) files reports and disclosures with the U.S. Securities and Exchange Commission (SEC) in connection with its listing on the Nasdaq Global Select Market and its status as a public company. These filings provide detailed information on its data streaming business, financial condition, and significant corporate events.
Among the key documents for CFLT are Form 10-K annual reports and Form 10-Q quarterly reports, which describe Confluent’s operations as a data streaming platform provider, outline its revenue from subscriptions and services, and discuss risks and other disclosures. Investors often review these filings to understand how Confluent presents its business model, including offerings such as Confluent Cloud, Confluent Platform, WarpStream, Confluent Private Cloud, Confluent Intelligence, Streaming Agents, Real-Time Context Engine, and Tableflow.
Confluent also uses Form 8-K current reports to disclose material events. For example, a Form 8-K dated December 8, 2025 describes an Agreement and Plan of Merger with International Business Machines Corporation (IBM) and a wholly owned IBM subsidiary. That filing outlines the proposed merger structure, the cash consideration for shares, the treatment of equity awards, closing conditions, termination rights, and potential termination fees. Other 8-K filings referenced in the available data report the release of quarterly financial results.
On this SEC filings page, users can access Confluent’s historical and ongoing disclosures, including 10-K, 10-Q, and 8-K filings, as well as proxy materials related to the IBM transaction once filed. The platform also surfaces Form 4 insider transaction reports and other ownership-related filings when available, allowing investors to monitor changes in holdings by directors and officers.
Stock Titan enhances these filings with AI-powered summaries that explain the key points of lengthy documents, highlight major risk factors, and clarify complex transaction terms. Real-time updates from the SEC’s EDGAR system help ensure that new CFLT filings, including those related to the pending IBM merger, are quickly available with plain-language explanations.
Confluent, Inc. reported that the U.S. antitrust waiting period required under the Hart-Scott-Rodino Act for its proposed merger with IBM expired at 11:59 p.m. Eastern Time on January 12, 2026, satisfying a key regulatory condition for closing.
The merger would combine Confluent with a wholly owned IBM subsidiary, after which Confluent would become a wholly owned IBM subsidiary. Completion of the transaction still depends on other customary closing conditions, including approvals or authorizations under antitrust and foreign investment laws in specified non-U.S. jurisdictions and approval by Confluent stockholders at a special meeting.
Confluent agreed to be acquired by IBM in an all-cash merger. IBM will buy Confluent for $31.00 in cash per share of Class A or Class B common stock, a premium of about 35% to Confluent’s 30‑day volume‑weighted average price as of December 5, 2025. A special virtual stockholder meeting on February 12, 2026 will ask investors to approve the merger agreement, a non‑binding vote on merger‑related executive compensation, and a possible adjournment to solicit more proxies. If approved and conditions such as antitrust clearances are satisfied, Confluent will become a wholly owned IBM subsidiary and its stock will be delisted. Stockholders who do not vote for the merger and follow strict Delaware procedures may instead seek a court‑determined “fair value” in cash via appraisal rights.
Confluent, Inc. has agreed to be acquired by IBM for cash. International Business Machines Corporation will acquire Confluent via a merger in which an IBM subsidiary will merge into Confluent, leaving Confluent as a wholly owned IBM subsidiary. If the merger closes, stockholders will receive $31.00 in cash per share of Class A or Class B common stock, without interest and less applicable taxes, representing a 35% premium to Confluent’s 30‑day volume‑weighted average price as of December 5, 2025.
A special virtual stockholder meeting in 2026 will ask investors to vote on adopting the merger agreement, approving merger‑related executive compensation on an advisory basis, and a possible adjournment to solicit additional proxies. A special independent board committee and the full Board unanimously determined the deal and consideration are fair and in the best interests of stockholders and recommend voting “FOR” all proposals. Stockholders who do not vote for the merger and follow strict Delaware procedures may instead seek a court‑determined cash payment for the “fair value” of their shares.
Confluent, Inc.'s chief financial officer reported a disposition of 6,667 shares of Class A common stock on 12/12/2025. The transaction, coded "G" and recorded at a price of $0 per share, left the officer with 582,071 shares beneficially owned on a direct basis. The report was filed by a single reporting person in their capacity as an officer of the company.
Confluent, Inc.'s chief executive officer and director reported exercising stock options for Class B common stock, converting those shares into Class A common stock and then selling the resulting Class A shares. On 12/12/2025, he converted 506,000 shares of Class B into Class A and sold 506,000 Class A shares at prices ranging from $30.02 to $30.10. On 12/15/2025, he converted 232,500 shares of Class B into Class A and sold 232,500 Class A shares at prices between $30.05 and $30.14.
After these transactions, he directly owned 339,367 shares of Class A common stock. The filing also shows additional positions related to Class A common stock held indirectly through family trusts, including 149,984 shares in a 2018 revocable trust and 1,000,000-share positions in each of two 2019 irrevocable trusts. The 232,500-share sale on 12/15/2025 was made under a Rule 10b5-1 trading plan adopted on August 15, 2024.
Confluent, Inc. director reported an insider transaction in company stock. On 12/10/2025, the director sold 1,074 shares of Class A common stock at $30 per share, and after this trade beneficial ownership stood at 11,524 shares held directly.
The sale was executed under a pre-arranged 10b5-1 Plan dated September 12, 2024, which is designed to meet the affirmative defense conditions of Rule 10b5-1(c) for trading according to a preset plan.
Confluent, Inc. director reported insider transactions in Class A common stock. On 12/10/2025, entities controlled by the director sold 15,476 shares at $30 per share under a Rule 10b5-1 trading plan adopted on December 13, 2024, leaving 1,061,542 shares indirectly owned.
On 12/12/2025, those entities disposed of another 336,000 shares as a gift at $0, reducing indirect holdings to 725,542 shares. The director also holds 20,861 shares directly.
Confluent, Inc. director reported equity transactions on December 10, 2025. The director exercised stock options to buy 23,100 shares of Class B common stock at $2.24 per share, which converted into an equal number of Class A shares. The director then sold 23,100 Class A shares at prices ranging from $30.00 to $30.02 under a Rule 10b5-1 trading plan adopted June 10, 2025. After these trades, the director held 28,549 Class A shares directly and 1,787 Class A shares indirectly through a trust.
A Confluent, Inc. director reported option exercises, share conversions and a planned stock sale. On 12/10/2025, the director exercised stock options for 62,500 shares of Class B Common Stock at $19.95 per share, which are convertible into Class A Common Stock on a one-for-one basis.
On the same date, 62,500 shares of Class A Common Stock were acquired through conversion and 62,500 Class A shares were sold under a Rule 10b5-1 trading plan dated March 13, 2025 at prices ranging from $30.00 to $30.005 per share. After these transactions, the director directly owned 28,549 shares of Class A Common Stock and 187,500 derivative securities.
Confluent, Inc. has agreed to be acquired by IBM in an all-cash merger. Under a signed Merger Agreement, an IBM subsidiary will merge into Confluent, which will become a wholly owned IBM subsidiary. Each share of Confluent Class A and Class B common stock outstanding immediately before closing will be converted into the right to receive $31.00 in cash, without interest and subject to withholding taxes. The merger is expected to close by the middle of 2026, subject to customary closing conditions.
A special committee of independent directors and the full board unanimously determined that the merger and its terms are advisable, fair to, and in the best interests of stockholders, and recommend stockholder approval without a majority-of-the-minority requirement. Stockholders holding approximately 62% of the voting power have signed a Voting Agreement to support the deal, with a reduced 35% voting commitment if the board changes its recommendation. Confluent must pay IBM a $453,600,000 termination fee in certain circumstances. CEO Edward (Jay) Kreps has an offer to join IBM post-closing, including a retention RSU award and potential accelerated vesting of certain RSUs upon qualifying termination after closing.
FAQ
What is the current stock price of Confluent (CFLT)?
What is the market cap of Confluent (CFLT)?
